Constipation in Parkinson's Disease: A Systematic Review and Meta-Analysis.

IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY
Lulu Yao, Wei Liang, Jiahao Chen, Qian Wang, Xiaobo Huang
{"title":"Constipation in Parkinson's Disease: A Systematic Review and Meta-Analysis.","authors":"Lulu Yao,&nbsp;Wei Liang,&nbsp;Jiahao Chen,&nbsp;Qian Wang,&nbsp;Xiaobo Huang","doi":"10.1159/000527513","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Constipation is a common nonmotor symptom of Parkinson's disease (PD) and has been reported to increase the risk of developing PD. However, previous studies have yielded conflicting results. Understanding this correlation may promote early diagnosis and treatment of PD, which could help patients improve their quality of life. This study aimed to investigate the association between constipation and PD onset.</p><p><strong>Methods: </strong>The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines. We searched the Medline, Embase, Scopus, SINOMED, and Cochrane databases as well as specific journals from inception to September 2021 for observational studies that evaluated the association between constipation and the risk of PD. The Newcastle-Ottawa Scale was used to evaluate the methodological quality of the included studies. Associations were summarized as odds ratios (ORs) using a random-effects model. Subgroup, meta-regression, and sensitivity analyses were performed.</p><p><strong>Results: </strong>Seventeen studies comprising 3,024,193 participants (case-control = 1,636,831; cohort = 1,387,362) were eligible for inclusion. The pooled OR for the association between constipation and PD was 2.36 (95% confidence interval: 1.93-2.88), although strong heterogeneity was observed (I2 = 90%, p < 0.01). Subgroup and meta-regression analyses indicated that study design and disease duration were the major sources of heterogeneity. A sensitivity analysis confirmed the stability of the outcomes. In addition, the prevalence of among those with prodromal PD was 20%, whereas it was only 11% in the control group (p < 0.01). Moreover, there were no significant age-based differences in constipation between the prodromal stage of PD patients and the controls (p > 0.05).</p><p><strong>Conclusion: </strong>Constipation has a relatively high incidence in the prodromal phase of PD and is associated with an increased risk of developing PD.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":"86 1","pages":"34-44"},"PeriodicalIF":2.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000527513","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Introduction: Constipation is a common nonmotor symptom of Parkinson's disease (PD) and has been reported to increase the risk of developing PD. However, previous studies have yielded conflicting results. Understanding this correlation may promote early diagnosis and treatment of PD, which could help patients improve their quality of life. This study aimed to investigate the association between constipation and PD onset.

Methods: The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines. We searched the Medline, Embase, Scopus, SINOMED, and Cochrane databases as well as specific journals from inception to September 2021 for observational studies that evaluated the association between constipation and the risk of PD. The Newcastle-Ottawa Scale was used to evaluate the methodological quality of the included studies. Associations were summarized as odds ratios (ORs) using a random-effects model. Subgroup, meta-regression, and sensitivity analyses were performed.

Results: Seventeen studies comprising 3,024,193 participants (case-control = 1,636,831; cohort = 1,387,362) were eligible for inclusion. The pooled OR for the association between constipation and PD was 2.36 (95% confidence interval: 1.93-2.88), although strong heterogeneity was observed (I2 = 90%, p < 0.01). Subgroup and meta-regression analyses indicated that study design and disease duration were the major sources of heterogeneity. A sensitivity analysis confirmed the stability of the outcomes. In addition, the prevalence of among those with prodromal PD was 20%, whereas it was only 11% in the control group (p < 0.01). Moreover, there were no significant age-based differences in constipation between the prodromal stage of PD patients and the controls (p > 0.05).

Conclusion: Constipation has a relatively high incidence in the prodromal phase of PD and is associated with an increased risk of developing PD.

帕金森病便秘:系统回顾和荟萃分析。
便秘是帕金森病(PD)的一种常见的非运动症状,有报道称便秘会增加患PD的风险。然而,之前的研究得出了相互矛盾的结果。了解这种相关性可以促进PD的早期诊断和治疗,从而帮助患者提高生活质量。本研究旨在探讨便秘与PD发病之间的关系。方法:本研究按照流行病学观察性研究的首选报告项目(PRISMA)和荟萃分析(MOOSE)指南进行。我们检索了Medline, Embase, Scopus, SINOMED和Cochrane数据库以及从成立到2021年9月的特定期刊,以评估便秘与PD风险之间关系的观察性研究。纽卡斯尔-渥太华量表用于评价纳入研究的方法学质量。使用随机效应模型将关联总结为比值比(ORs)。进行亚组、元回归和敏感性分析。结果:17项研究包括3,024,193名参与者(病例对照= 1,636,831;队列= 1,387,362)符合纳入条件。便秘和PD之间关联的合并OR为2.36(95%可信区间:1.93-2.88),尽管存在很强的异质性(I2 = 90%, p < 0.01)。亚组和荟萃回归分析表明,研究设计和疾病持续时间是异质性的主要来源。敏感性分析证实了结果的稳定性。此外,PD前驱期患者的患病率为20%,而对照组仅为11% (p < 0.01)。PD患者前驱期便秘与对照组无明显年龄差异(p > 0.05)。结论:便秘在PD的前驱期发生率较高,且与PD发病风险增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Neurology
European Neurology 医学-临床神经学
CiteScore
4.40
自引率
4.20%
发文量
51
审稿时长
4-8 weeks
期刊介绍: ''European Neurology'' publishes original papers, reviews and letters to the editor. Papers presented in this journal cover clinical aspects of diseases of the nervous system and muscles, as well as their neuropathological, biochemical, and electrophysiological basis. New diagnostic probes, pharmacological and surgical treatments are evaluated from clinical evidence and basic investigative studies. The journal also features original works and reviews on the history of neurology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信